Carrageenan-based gel retains limited anti-HIV-1 activity 8-24 hours after vaginal application by HIV-infected thai women enrolled in a phase I safety trial

  • Richard E. Haaland
  • , Thanyanan Chaowanachan
  • , Tammy Evans-Strickfaden
  • , Janneke H. van de Wijgert
  • , Peter H. Kilmarx
  • , Catherine A. McLean
  • , Clyde E. Hart

Research output: Contribution to journalComment/Letter to the editorAcademic

Original languageEnglish
JournalJournal of Acquired Immune Deficiency Syndromes
Volume61
Issue number5
DOIs
Publication statusPublished - 15 Dec 2012
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this